PPTA Twitter

PlasmaProteins #Plasmaprotein therapies give individuals the ability to lead a normal life. “For patients with CIDP, access to treatment is vital to maintain physical autonomy.” Read Jean-Philippe’s story: bit.ly/2TvhoS2 #PlasmaDonorsSaveLives
About 15 hours ago.
PlasmaProteins Thank you for recognizing #IPAW2019 , @GovMurphy . pic.twitter.com/4s5lQFlQZW
6 days ago.

Plasma Protein Therapeutics Association

The Plasma Protein Therapeutics Association (PPTA) represents the private sector manufacturers of plasma-derived and recombinant analog therapies, collectively known as plasma protein therapies and the collectors of source plasma used for fractionation. These therapies are used by small patient populations worldwide to treat a variety of rare diseases and serious medical conditions.

Erica XLA

PPTA works globally to:

    • Advocate for access to and affordability of therapies for patients
    • Engage in constructive dialogue with regulatory agencies
    • Collaborate with patient advocacy organizations

PPTA also administers standards and programs that help ensure the quality and safety of plasma collection and manufacturing and protect both donors and patients.

Copyright © 2018 PPTA. All rights reserved. (202) 789-3100